A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms
International Journal of Molecular Sciences · 25.07.2026 · 27 (15) · 6629
DOI: 10.3390/ijms27156629 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.07.2026. Verfasst von Giulia Valdiserra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Enterococcus, Colitis, Probiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cerbios-Pharma SA.
Abstract (Originalsprache)
(1) Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits, linked to dysbiosis and inflammation. Currently available treatments, focused on symptom management, displayed limited efficacy. Recent research highlights microbiota modulation as a potential therapeutic strategy to restore intestinal barrier integrity; (2) A dextran sulfate sodium (DSS)-induced mouse model of post-colitis IBS-like symptoms was performed to evaluate the effect of a novel mixture of Enterococcus lactis SF68®, butyrate, and folate. Disease activity index and spleen weight were assessed. Markers of gut inflammation, intestinal barrier alterations, and gut butyrate bioavailability were measured. The activity of colonic mitochondria was also analyzed; (3) Supplementation with the novel mixture significantly reduced spleen weight and cytokine levels. The intestinal epithelial barrier was restored through an increase in claudin-1, occludin, and defensin 1–3 and a reduction in LBP plasma level. Treatment with the mixture enhanced the expression of butyrate transporters in mice. Mitochondrial activity markers, including citrate synthase and Cytochrome c oxidase, were improved by treatment; (4) The novel mixture containing Enterococcus lactis, butyrate, and folate exerted a protective effect against post-inflammatory IBS by reducing local inflammation, restoring intestinal barrier integrity, and enhancing butyrate bioavailability, suggesting its potential for managing post-inflammatory IBS symptoms effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Unit of Histology and Medical Embryology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Unit of Experimental Biology and Genetics, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Cerbios-Pharma SA, 6917 Lugano, Switzerland.
ORCID-Profile: Clelia Di Salvo, Letizia Campigli, Vanessa D'Antongiovanni, Carolina Pellegrini, Lara Testai, Laura Benvenuti, Matteo Fornai, Luca Antonioli
Förderung
- Cerbios-Pharma SA
Zitieren
APA
Valdiserra, G., Di Salvo, C., Campigli, L., D'Antongiovanni, V., Pellegrini, C., Benedetti, G., Testai, L., Segnani, C., Benvenuti, L., Coppolecchia, R., Bernardini, N., Fornai, M., & Antonioli, L. (2026). A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms. International Journal of Molecular Sciences, 27(15), 6629. https://doi.org/10.3390/ijms27156629
Vancouver
Valdiserra G, Di Salvo C, Campigli L, D'Antongiovanni V, Pellegrini C, Benedetti G, et al. A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms. International Journal of Molecular Sciences. 2026;27(15):6629. doi:10.3390/ijms27156629
BibTeX
@article{Valdiserra2026,
author = {Valdiserra, Giulia and Di Salvo, Clelia and Campigli, Letizia and D'Antongiovanni, Vanessa and Pellegrini, Carolina and Benedetti, Giada and Testai, Lara and Segnani, Cristina and Benvenuti, Laura and Coppolecchia, Raffaella and Bernardini, Nunzia and Fornai, Matteo and Antonioli, Luca},
title = {A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6629},
doi = {10.3390/ijms27156629}
}
EUVIMED